HomeCategoryP28 News and Press Releases | Paragon 28

Paragon 28 is pleased to announce the launch of its ParaDerm® NF Dermal Matrix providing surgeons a structural allograft for applications beneath the skin in cases where additional structural value is desired.

Paragon 28 Announces Addition of B. Kristine Johnson and Kristina Wright to its Board of Directors December 01, 2021 07:00 AM Eastern Standard Time ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today the appointment of B. Kristine Johnson and...

Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced today that the U.S. Food and Drug Administration (FDA) has given 501(k) marketing clearance to its Circular External Fixation System. The Circular External Fixation System, expected to commercially launch in early 2022, will...

Paragon 28, Inc. Increases its Robust Hindfoot Fusion Plating Offering, Launching the Silverback™ Span Plating System Paragon 28® is pleased to announce the launch of its Silverback™ Span Plating System, which was specifically designed to be used in combination with a structural allograft or a titanium cage in cases where a significant void is present...

Paragon 28®, Inc. Increases its Robust Hindfoot Fusion Plating Offering, Launching the Silverback™ Straddle Plating System ENGLEWOOD, Colo., Aug. 19, 2021 /PRNewswire/ — Paragon 28® is pleased to announce the launch of its Silverback™ Straddle Plating System designed to supplement the Phantom® Hindfoot TTC Fusion Nail allowing surgeons to create a plate and nail construct for tibiotalocalcaneal...

Paragon 28, Inc. Names Scott Drake to its Board of Directors ENGLEWOOD, Colo., Aug. 10, 2021 /PRNewswire/ — Paragon 28, Inc. announced today that Scott Drake has joined its Board of Directors. “Scott is an accomplished leader in the medical technology space, possessing both outstanding strategic vision and operational know-how,” said Albert DaCosta, Co-Founder, President, and Chief Executive Officer of Paragon...

DENVER, June 1, 2021 /PRNewswire/ — Paragon 28, Inc., a market-leading orthopedic medical device company focused exclusively on the foot-and-ankle, today announced that the Company has acquired the product lines of Additive Orthopaedics (“Additive”). The Additive 3D-printed Patient Specific Talus Spacer was approved on February 17, 2021 by the US Food and Drug Administration (“FDA”) and is the first...

ENGLWOOD, Colo., May 20, 2021 /PRNewswire/ — Paragon 28 is pleased to announce the launch of the BEAST™ Injectable Putty, BEAST PLUS™, and BEAST™ Osteobiologic Sponge (BOB™)! All three grafts have a high osteoinductive potential, excellent handling characteristics, and are processed using a proprietary method which ensures preservation of native bone morphogenic proteins (BMP), notably 2,...